US2007026012A1PendingUtilityA1
Compositions and methods for monitoring and altering protein folding and solubility
Est. expiryAug 1, 2025(expired)· nominal 20-yr term from priority
C12N 15/1086C07K 2319/034C12N 15/1034C12N 15/625C12N 15/62
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the fields of microbiology, molecular biology and protein biochemistry. More particularly, it relates to compositions and methods for analyzing and altering (e.g., enhancing or inhibiting) protein folding and solubility.
Claims
exact text as granted — not AI-modified1 . A composition comprising a fusion protein, wherein said fusion protein comprises a ssTorA signal peptide, an antibody and a TEM1 β-lactamase.
2 - 24 . (canceled)
25 . The composition of claim 1 , wherein said antibody is selected from the group consisting of an immunoglobulin light chain, antibodies, antibody fragments (such as single-chain Fv fragment (scFv), single-chain antibody (scAb), F AB antibody fragment.
26 . The composition of claim 25 , wherein said antibody is a human antibody.Join the waitlist — get patent alerts
Track US2007026012A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.